• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

木香烯内酯对人乳腺癌细胞端粒酶活性的抑制作用。

Inhibitory effects of costunolide on the telomerase activity in human breast carcinoma cells.

作者信息

Choi Sang-Ho, Im Eunok, Kang Hyun Kyung, Lee Ji-Hyeon, Kwak Hi-Suk, Bae Young-Tae, Park Hee-Juhn, Kim Nam Deuk

机构信息

Department of Pharmacy, College of Pharmacy, and Research Institute for Drug Development, Pusan National University, Busan 609-735, South Korea.

出版信息

Cancer Lett. 2005 Sep 28;227(2):153-62. doi: 10.1016/j.canlet.2005.01.011.

DOI:10.1016/j.canlet.2005.01.011
PMID:16112418
Abstract

Costunolide, a natural sesquiterpene compound, has been known having cytotoxic and chemopreventive effects on various human cancer cells. In the present study, we examined the effects of costunolide on telomerase activity and on the components of telomerase in MCF-7 (wild-type p53) and MDA-MB-231 (mutant p53) cells. We found that costunolide inhibited the growth and telomerase activity of MCF-7 and MDA-MB-231 cells in a concentration- and time-dependent manner. The expression of hTERT mRNA was also inhibited but hTR mRNA was not. In addition, the bindings of transcription factors in hTERT promoters were significantly decreased in both cells by the treatment of costunolide. These results suggest that costunolide inhibited the growth of both MCF-7 and MDA-MB-231 cells and this effect was mediated at least in part by a significant reduction in telomerase activity.

摘要

木香烯内酯是一种天然倍半萜化合物,已知其对多种人类癌细胞具有细胞毒性和化学预防作用。在本研究中,我们检测了木香烯内酯对MCF-7(野生型p53)和MDA-MB-231(突变型p53)细胞中端粒酶活性及端粒酶组分的影响。我们发现木香烯内酯以浓度和时间依赖性方式抑制MCF-7和MDA-MB-231细胞的生长及端粒酶活性。hTERT mRNA的表达也受到抑制,但hTR mRNA未受影响。此外,经木香烯内酯处理后,两种细胞中hTERT启动子上转录因子的结合显著减少。这些结果表明,木香烯内酯抑制MCF-7和MDA-MB-231细胞的生长,且这种作用至少部分是由端粒酶活性的显著降低介导的。

相似文献

1
Inhibitory effects of costunolide on the telomerase activity in human breast carcinoma cells.木香烯内酯对人乳腺癌细胞端粒酶活性的抑制作用。
Cancer Lett. 2005 Sep 28;227(2):153-62. doi: 10.1016/j.canlet.2005.01.011.
2
Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells.野生型p53对人肿瘤细胞中端粒酶逆转录酶mRNA表达的下调作用。
Oncogene. 2000 Oct 26;19(45):5123-33. doi: 10.1038/sj.onc.1203890.
3
Potent inhibition of human telomerase by helenalin.海伦alin对人端粒酶的强效抑制作用。
Cancer Lett. 2005 Sep 28;227(2):169-74. doi: 10.1016/j.canlet.2004.11.045. Epub 2004 Dec 24.
4
Regulation of telomerase activity in Jurkat T cells by transcription factors Sp1 and Sp3.转录因子Sp1和Sp3对Jurkat T细胞中端粒酶活性的调控。
Di Yi Jun Yi Da Xue Xue Bao. 2002 Jun;22(6):481-5.
5
Introduction of p16INK4a inhibits telomerase activity through transcriptional suppression of human telomerase reverse transcriptase expression in human gliomas.p16INK4a的导入通过转录抑制人胶质瘤中人类端粒酶逆转录酶的表达来抑制端粒酶活性。
Int J Oncol. 2004 May;24(5):1213-20.
6
Autocrine transforming growth factor beta suppresses telomerase activity and transcription of human telomerase reverse transcriptase in human cancer cells.自分泌转化生长因子β抑制人类癌细胞中的端粒酶活性及人端粒酶逆转录酶的转录。
Cell Growth Differ. 2001 Feb;12(2):119-27.
7
Down-regulation of hTERT expression plays an important role in 15-deoxy-Delta12,14-prostaglandin J2-induced apoptosis in cancer cells.hTERT表达的下调在15-脱氧-Δ12,14-前列腺素J2诱导的癌细胞凋亡中起重要作用。
Int J Oncol. 2009 May;34(5):1363-72.
8
Inhibition of human telomerase reverse transcriptase by nonsteroidal antiinflammatory drugs in colon carcinoma.非甾体抗炎药对结肠癌中人类端粒酶逆转录酶的抑制作用
Cancer. 2006 Mar 15;106(6):1243-9. doi: 10.1002/cncr.21694.
9
[Effect of HSP90 function inhibited on the telomerase and P53 mutant in breast cancer cells].[热休克蛋白90(HSP90)功能抑制对乳腺癌细胞中端粒酶及P53突变体的影响]
Sichuan Da Xue Xue Bao Yi Xue Ban. 2008 Mar;39(2):181-3.
10
Real-time quantitative analysis for human telomerase reverse transcriptase mRNA and human telomerase RNA component mRNA expressions as markers for clinicopathologic parameters in urinary bladder cancer.人端粒酶逆转录酶mRNA和人端粒酶RNA组分mRNA表达作为膀胱癌临床病理参数标志物的实时定量分析
Int J Urol. 2006 Apr;13(4):401-8. doi: 10.1111/j.1442-2042.2006.01300.x.

引用本文的文献

1
Telomeres, telomerase, and cancer: mechanisms, biomarkers, and therapeutics.端粒、端粒酶与癌症:作用机制、生物标志物及治疗方法
Exp Hematol Oncol. 2025 Jan 27;14(1):8. doi: 10.1186/s40164-025-00597-9.
2
Artemvulactone E isolated from L. ameliorates lipopolysaccharide-induced inflammation in both RAW264.7 and zebrafish model.从该植物中分离出的青蒿内酯E可改善脂多糖诱导的RAW264.7细胞和斑马鱼模型中的炎症。
Front Pharmacol. 2024 Jul 18;15:1415352. doi: 10.3389/fphar.2024.1415352. eCollection 2024.
3
Individual lipid transfer proteins from Tanacetum parthenium show different specificity for extracellular accumulation of sesquiterpenes.
来自豚草的个体脂质转移蛋白对倍半萜的细胞外积累表现出不同的特异性。
Plant Mol Biol. 2023 Jan;111(1-2):153-166. doi: 10.1007/s11103-022-01316-2. Epub 2022 Oct 18.
4
Sesquiterpene lactones of : Pharmacology, pharmacokinetics, toxicity, and structure-activity relationship.倍半萜内酯的:药理学、药代动力学、毒性及构效关系
Chin Herb Med. 2021 Feb 16;13(2):167-176. doi: 10.1016/j.chmed.2020.11.005. eCollection 2021 Apr.
5
Costunolide Induces Autophagy and Apoptosis by Activating ROS/MAPK Signaling Pathways in Renal Cell Carcinoma.木香烃内酯通过激活肾细胞癌中的ROS/MAPK信号通路诱导自噬和凋亡。
Front Oncol. 2020 Oct 26;10:582273. doi: 10.3389/fonc.2020.582273. eCollection 2020.
6
Terpenoids as Potential Geroprotectors.萜类化合物作为潜在的老年保护剂。
Antioxidants (Basel). 2020 Jun 17;9(6):529. doi: 10.3390/antiox9060529.
7
Targeted Covalent Inhibition of Telomerase.靶向端粒酶的共价抑制。
ACS Chem Biol. 2020 Mar 20;15(3):706-717. doi: 10.1021/acschembio.9b00945. Epub 2020 Feb 24.
8
Costunolide-A Bioactive Sesquiterpene Lactone with Diverse Therapeutic Potential.Costunolide-A 一种具有多种治疗潜力的生物活性倍半萜内酯。
Int J Mol Sci. 2019 Jun 14;20(12):2926. doi: 10.3390/ijms20122926.
9
Telomerase Inhibitors from Natural Products and Their Anticancer Potential.天然产物来源的端粒酶抑制剂及其抗癌潜力。
Int J Mol Sci. 2017 Dec 21;19(1):13. doi: 10.3390/ijms19010013.
10
Costunolide and dehydrocostuslactone combination treatment inhibit breast cancer by inducing cell cycle arrest and apoptosis through c-Myc/p53 and AKT/14-3-3 pathway.**费用诺内酯和脱氢木香内酯联合治疗通过 c-Myc/p53 和 AKT/14-3-3 通路诱导细胞周期停滞和凋亡抑制乳腺癌。**
Sci Rep. 2017 Jan 24;7:41254. doi: 10.1038/srep41254.